Drug General Information
Drug ID
D0Q4EJ
Drug Name
Anti-EGFR V III CAR-T cells
Drug Type
CAR T Cell Therapy
Indication Glioma [ICD-11: 2A00.0; ICD-9: 191] Phase 1/2 [1]
Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0] Phase 1/2 [1]
Lung cancer [ICD-11: 2C25.0; ICD-9: 162] Phase 1/2 [1]
Company
Shenzhen BinDeBio Ltd.
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT03638206) Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.